Troubled times – Baton Rouge-based Amedisys has come under investigation for allegedly altering the course of patient care treatment to trigger higher federal reimbursements.

In 2006, the top managers at Amedisys gathered for another company meeting. On the agenda was a PowerPoint presentation called “Help With Reports.” To an onlooker, the slideshow was, in most respects, just as mundane as the title implied. Clip art of a stethoscope across the top of each page, bold arrows and occasional twisted